IP Library Granted Patent US 11,865,280
Granted Patent B2
US 11,865,280 · App. 17/125,307 · Granted Jan 9, 2024

Limited-access, reduced-pressure systems and methods

Inventor: Bruce McNeil (San Antonio, TX)
Assignee: 3M Innovative Properties Company
A61M27/00A61F13/00068A61F13/0216A61M1/913A61M1/915A61M1/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,865,280
App. No.
17/125,307
Granted
Jan 9, 2024
Kind
B2
Abstract

A reduced-pressure treatment system for applying reduced pressure to a tissue site at a limited-access location on a patient includes a reduced-pressure source, a treatment manifold for placing proximate the tissue site and operable to distribute reduced pressure to the tissue site, and a sealing member for placing over the tissue site and operable to form a pneumatic seal over the tissue site. The reduced-pressure treatment system also includes a reduced-pressure bridge and a moisture-removing device on at least portion of the reduced-pressure bridge. The reduced-pressure bridge includes a delivery manifold operable to transfer the reduced pressure to the treatment manifold, an encapsulating envelope at least partially enclosing the delivery manifold and having a patient-facing side, and a reduced-pressure-interface site formed proximate one end of the reduced-pressure bridge.

Claims (25)

1. A reduced-pressure bridge for delivering reduced pressure to a tissue site from a remote site, the reduced-pressure bridge comprising:

a first encapsulating envelope at least partially enclosing a first manifold;

a second encapsulating envelope at least partially enclosing a second manifold;

a first aperture proximate a first end of the reduced-pressure bridge and configured to be directly coupled to a sealing member that is configured to provide a fluid seal over the tissue site;

a second aperture proximate a second end of the reduced-pressure bridge and configured to be coupled to a reduced-pressure interface positioned at the remote site; and

a fenestration positioned between the first end and the second end.

2. The reduced-pressure bridge of claim 1 , further comprising a wicking material on the reduced-pressure bridge.

3. The reduced-pressure bridge of claim 2 , wherein the wicking material is adapted to contact a remote tissue portion and to absorb liquid from the remote tissue portion.

4. The reduced-pressure bridge of claim 2 , wherein the wicking material comprises a cloth-material drape.

5. The reduced-pressure bridge of claim 2 , wherein the wicking material comprises a non-woven fabric.

6. The reduced-pressure bridge of claim 2 , wherein the wicking material covers at least 50 percent of a side of the reduced-pressure bridge.

7. The reduced-pressure bridge of claim 2 , wherein the wicking material covers at least 70 percent of a side of the reduced-pressure bridge.

8. The reduced-pressure bridge of claim 2 , wherein the wicking material covers at least 80 percent of a side of the reduced-pressure bridge.

9. The reduced-pressure bridge of claim 2 , wherein the wicking material extends along a length of the reduced-pressure bridge.

10. The reduced-pressure bridge of claim 1 , wherein the first encapsulating envelope and the second encapsulating envelope comprise a polyurethane material.

11. The reduced-pressure bridge of claim 1 , wherein the reduced-pressure bridge has a length (L), and wherein L>120 mm.

12. The reduced-pressure bridge of claim 1 , wherein the reduced-pressure bridge has a length (L), and wherein L>200 mm.

13. The reduced-pressure bridge of claim 1 , wherein the reduced-pressure bridge has a length (L) and a width (W), and wherein L>(4*W).

14. The reduced-pressure bridge of claim 1 , wherein the first manifold is a foam material.

15. The reduced-pressure bridge of claim 1 , wherein the first encapsulating envelope is formed by a first encapsulating member and a second encapsulating member, and wherein the second encapsulating envelope is formed by the second encapsulating member and a third encapsulating member.

16. The reduced-pressure bridge of claim 15 , wherein the first encapsulating member has a first perimeter portion, wherein the second encapsulating member has a second perimeter portion, and wherein the first perimeter portion is coupled to the second perimeter portion.

17. The reduced-pressure bridge of claim 1 , wherein the first aperture is configured to be in fluid communication with the tissue site through the sealing member.

18. The reduced-pressure bridge of claim 1 , further comprising an adhesive on the first end configured to couple the reduced-pressure bridge to the sealing member.

19. The reduced-pressure bridge of claim 1 , wherein the reduced-pressure bridge is configured to transfer reduced pressure from the remote location to the tissue site through the first aperture.

20. The reduced-pressure bridge of claim 1 , wherein the reduced-pressure bridge is configured to distribute fluids to the tissue site.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
Continuity (6)
Continuation 15651585 · Jul 17, 2017
Continuation 14045946 · Oct 4, 2013
Continuation 13348306 · Jan 11, 2012
Division 12403296 · Mar 12, 2009
Provisional Application 61103566 · Oct 8, 2008
Related Publication 20210100939A1 · Apr 8, 2021